Cardiovascular illnesses, such as high blood pressure and heart problems, are often treated with angiotensin-converting enzyme (ACE) inhibitors. The ACE inhibitors lower blood pressure by relaxing ... Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as ...

Understanding the Context

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may represent effective migraine prophylactic treatments. PHILADELPHIA — Angiotensin-converting enzyme (ACE) inhibitors and ... In patients with hypertension, angiotensin-converting enzyme inhibitors (ACEIs) did not reduce the risk of age-related macular degeneration (AMD) compared with calcium channel blockers (CCBs). Several ...

Key Insights

Objective: To compare angiotensin-converting enzyme (ACE) inhibitor use in patients with type 2 diabetes at 1 year and 3 years after guidelines were published. Study Design: Retrospective database ... Objectives: To use a population management strategy to increase the proportion of patients with coronary artery disease (CAD) and diabetes receiving target-dose angiotensin-converting enzyme (ACE) ... The Conversation: What we know about ACE inhibitors, high blood pressure and COVID‑19 Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new nationwide US observational study suggests that ACE inhibitors may protect against severe ...

Final Thoughts

News Medical: Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis Please provide your email address to receive an email when new articles are posted on . Angiotensin-converting enzyme inhibitors in patients with systemic sclerosis and concomitant arterial ... UPI: Study: ACE inhibitors for blood pressure increase protein that bolsters COVID-19